News Search Results
Nov 25, 2025, 09:45 ET To Educate the Public and Raise Awareness, Prevent Blindness Declares Fifth Annual Geographic Atrophy Week as Dec. 1-7, 2025
Advancements in Treatments for Geographic Atrophy," featuring Rajeev S. Ramchandran, MD, MBA, Associate Professor of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center."
More news about: Prevent Blindness
Nov 25, 2025, 09:00 ET Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis
schizophrenia, and bipolar disorder.Professor Peter van Wijngaarden, Executive Director and CEO of the Florey and Honorary Professor of Ophthalmology at the University of Melbourne, has a strong research interest in biomarkers of neurodegenerative diseases. "We are delighted to announce this research
More news about: Neurophet
Nov 25, 2025, 04:35 ET TCL CSOT Unveils "2025 Eye-Care Technology White Paper", Setting New Benchmarks for Natural-Light Display Standards
advanced display technologies and a subsidiary of TCL Technology (000100.SZ), in collaboration with the National Engineering Research Center for Ophthalmology & Optometry of Wenzhou Medical University in China, and leading industry partners including Lenovo, CVTE, TAL Education, the China Institute
More news about: TCL China Star Optoelectronics Technology
Nov 24, 2025, 13:29 ET U.S. Software as a Medical Device Market to Reach USD 715 Million by 2033 as AI-Driven Diagnostics and Digital Therapeutics Accelerate Adoption
hospitalizations.DiagnosticsDiagnostics accounted for 29% of the market, valued at USD 59 million. AI-based imaging analytics, digital pathology platforms, ophthalmology screening tools, and virtual ECG diagnostic engines are gaining strong adoption among U.S. hospitals. FDA-cleared AI diagnostic tools, especially
More news about: DataM Intelligence 4 Market Research LLP
Nov 24, 2025, 06:03 ET Cell Therapy Market Size Set to More Than Double by 2030 -- North America Leads, While Asia-Pacific Emerges as the Fastest-Growing Region, Says Mordor Intelligence
DiseasesOrthopedic & MusculoskeletalNeurological DisordersAutoimmune DisordersWound Healing & DermatologyOphthalmologyBy End UserHospitals & ClinicsSpecialty Cell- & Gene-Therapy CentersAcademic
More news about: Mordor Intelligence Private Limited
Nov 24, 2025, 03:07 ET Sectra at RSNA 2025: Supporting subspecialty workflows and photon-counting CT at the workstation to reduce burnout risk and improve patient care
Sectra will showcase its complete enterprise imaging portfolio comprised of diagnostic modules (radiology, cardiology, pathology, orthopaedics, ophthalmology, and genomics), with its VNA and PACS at its core. In the latest KLAS report for customer satisfaction, Sectra's PACS was placed first for the 12th consecutive
More news about: Sectra
Nov 23, 2025, 19:00 ET Innovent Biologics Enters Hang Seng Index and Two Other Major Indices; Global Capital Markets Recognize Leading Innovator's Value
company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that it has been successfully added as a constituent stock of the Hang Seng Index (HSI) following the release
More news about: Innovent Biologics
Nov 20, 2025, 07:01 ET SamaCare Launches SamaCare Plus: AI-Driven Touchless Prior Authorizations Built for Provider Control
Drug PAs Because SamaCare processes prior authorizations across rheumatology, neurology, oncology, ophthalmology, and infusion centers, SamaCare Plus leverages rich cross-specialty intelligence to choose the optimal path for each case, increasing approval likelihood
More news about: SamaCare
Nov 19, 2025, 02:48 ET Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics/bio-therapeutics
More news about: Piramal Pharma Solutions
Nov 19, 2025, 02:41 ET Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics/bio-therapeutics
More news about: Piramal Pharma Solutions
Nov 18, 2025, 09:00 ET AI That Saves Sight: Utah Clinic Uses Breakthrough Technology to Bring Specialty Eye Care Directly to Patients with Diabetes
by Digital Diagnostics. In just three months, the clinic has conducted nearly 100 eye exams, identifying roughly one in four patients for urgent ophthalmology referral and treatment.
More news about: Digital Diagnostics
Nov 17, 2025, 13:54 ET Prevent Blindness Names Matt MacDonald, EyeMed Vision Care, as Board of Directors Chair, Adds Three New Members
served on the Prevent Blindness Board of Directors from 2018 to 2024. Dr. Cadmus Rich has held progressive positions in ophthalmology research and development, previously as Medical Director/Senior Director at Quintiles, Head of Clinical Trial Management at Alcon, Therapeutic Unit
More news about: Prevent Blindness
Nov 13, 2025, 16:05 ET Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
for the mechanism of action behind KSI-101 At the recent American Academy of Ophthalmology (AAO) meetings, intraocular interleukin-6 inhibition was shown in Phase 3 clinical trials to deliver a meaningful improvement in vision and anatomy
More news about: Kodiak Sciences Inc.
Nov 13, 2025, 08:00 ET LARGE HEALTH SYSTEM IN SOUTHEAST US ADOPTS SECTRA'S CLOUD SERVICE ACROSS 11 SITES TO ENSURE RELIABILITY IN THEIR DELIVERY OF EXCELLENT PATIENT CARE
worldwide. Sectra offers a complete enterprise solution comprised of imaging modules (radiology, cardiology, pathology, orthopedics, genomics and ophthalmology), and a robust VNA. Over the last consecutive twelve years, Sectra has been awarded Best in KLAS for highest customer satisfaction. For more information,
More news about: Sectra
Nov 12, 2025, 16:00 ET Keenova to Participate in the Jefferies Global Healthcare Conference in London
need, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology and urology. Globally headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with
More news about: Keenova Therapeutics
Nov 10, 2025, 08:50 ET Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
the failure of drug manufacturers to warn consumers and medical professionals about these risks. A 2025 study published in JAMA Ophthalmology examined nine patients who developed optic nerve disorders after using GLP-1 medications, with the majority suffering from
More news about: Parker Waichman LLP
Nov 10, 2025, 07:00 ET Mallinckrodt Reports Third Quarter 2025 Financial Results
need, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology and urology. Globally headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with
More news about: Keenova Therapeutics
Nov 10, 2025, 06:30 ET Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
pipeline and expand its diversified brands portfolio across a wide range of therapeutic areas of significant unmet need, including rheumatology, ophthalmology, nephrology, pulmonology, neurology, urology, and orthopedics. This strategy is supported by strong commercial capabilities, a robust quality and
More news about: Keenova Therapeutics
Nov 09, 2025, 19:00 ET Innovent and SanegeneBio Announce Phase 1 Clinical Data for IBI3016 Presented at American Heart Association (AHA) 2025 Annual Meeting
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, jointly announced with Sanegene Bio USA Inc. (SanegeneBio), a global clinical-stage biotechnology company focused on developing
More news about: Innovent Biologics
Nov 05, 2025, 21:31 ET Prevent Blindness Declares Sixth Annual Thyroid Eye Disease (TED) Week to Educate Public on Condition That Can Threaten Sight and Mental Wellness
TED Community Organization; Prem Subramanian, MD, PhD, Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology and Vice Chair for Academic Affairs at
More news about: Prevent Blindness
Nov 05, 2025, 16:37 ET IMA Welcomes Six New Senior Fellows to Its Global Network; Independent Doctors Continue to Grow in Influence Across America's Healthcare Reform Landscape
Jersey) – Senior Fellow, Psychiatry Dr. John Fleishman (Ohio) – Senior Fellow, Neuro-Ophthalmology Dr. Adylle Varon (Texas) – Senior Fellow, Acupuncture and Oriental Medicine
More news about: Independent Medical Alliance
Nov 05, 2025, 12:57 ET Piramal Pharma Limited Announces Results for Q2 and H1 FY26
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Nov 05, 2025, 10:31 ET Hyaluronic Acid Products Market to Reach $20 billion, Globally, by 2034 at 7.7% CAGR: Allied Market Research
Market by Product Type (Hyaluronic Acid Injections, Hyaluronic Acid Eye Drops, and Others), Application (Aesthetics and Dermatology, Orthopedics, Ophthalmology, and Others), and End User (Hospitals, Specialty Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2025-2034". According
More news about: Allied Market Research
Nov 05, 2025, 07:57 ET Simple Solution Remains Out of Reach for Women: Glasses
Ophthalmology, shows that women are less likely to receive this kind of straightforward vision care, especially in Southeast Asia, East Asia, and Oceania,
More news about: Orbis International
Nov 05, 2025, 07:00 ET Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)
therapeutic landscape by becoming a safe, first-line unifying therapy for all causes of MESI." "At the recent American Academy of Ophthalmology meetings, intraocular interleukin-6 inhibition was shown in Phase 3 clinical trials to deliver a meaningful improvement in vision and anatomy in
More news about: Kodiak Sciences Inc.